Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
8 Apr 24 | CNSP CNS Pharmaceuticals | RSU Common Stock | Grant | Acquire A | No | No | 0 | 17,500 | 0.00 | 147,094 |
8 Apr 24 | CNSP CNS Pharmaceuticals | Option to purchase common stock Common Stock | Grant | Acquire A | No | No | 0.2586 | 17,500 | 4.53 k | 129,594 |
1 Feb 24 | CNSP CNS Pharmaceuticals | Common stock | Buy | Acquire P | No | No | 0.3 | 33,333 | 10.00 k | 33,458 |
1 Feb 24 | CNSP CNS Pharmaceuticals | Series B Warrant to purchase common stock Common Stock | Grant | Acquire A | No | No | 0.3 | 33,333 | 10.00 k | 112,094 |
1 Feb 24 | CNSP CNS Pharmaceuticals | Series A Warrant to purchase common stock Common Stock | Grant | Acquire A | No | No | 0.3 | 33,333 | 10.00 k | 78,761 |
21 Sep 23 | CNSP CNS Pharmaceuticals | Option to purchase common stock Common Stock | Grant | Acquire A | No | No | 1.09 | 68,961 | 75.17 k | 74,914 |
21 Sep 23 | CNSP CNS Pharmaceuticals | Option to purchase common stock Common Stock | Grant | Acquire A | No | No | 1.09 | 39,475 | 43.03 k | 45,428 |